Axcelis Technologies (NASDAQ:ACLS) EVP Gerald Blumenstock Sells 1,161 Shares of Stock

Axcelis Technologies, Inc. (NASDAQ:ACLS) EVP Gerald Blumenstock sold 1,161 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $152.70, for a total transaction of $177,284.70. Following the completion of the sale, the executive vice president directly owned 20,493 shares in the company, valued at approximately $3,129,281.10. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Axcelis Technologies Stock Up 2.9%

Shares of ACLS stock opened at $156.94 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.99 and a current ratio of 4.59. The firm’s 50-day moving average is $121.12 and its 200-day moving average is $98.30. The stock has a market cap of $4.82 billion, a price-to-earnings ratio of 48.89, a PEG ratio of 12.14 and a beta of 1.93. Axcelis Technologies, Inc. has a 52-week low of $55.93 and a 52-week high of $171.61.

Axcelis Technologies (NASDAQ:ACLS) last issued its earnings results on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The company had revenue of $198.96 million for the quarter, compared to analysts’ expectations of $195.03 million. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. Axcelis Technologies’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.88 EPS. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Sell-side analysts predict that Axcelis Technologies, Inc. will post 2.86 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ACLS. Royal Bank of Canada grew its stake in Axcelis Technologies by 3.8% in the 1st quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company’s stock valued at $5,838,000 after buying an additional 4,324 shares during the last quarter. AQR Capital Management LLC grew its stake in Axcelis Technologies by 4.9% in the 1st quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company’s stock valued at $1,774,000 after buying an additional 1,678 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Axcelis Technologies by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company’s stock valued at $963,000 after buying an additional 849 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Axcelis Technologies by 7.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock valued at $31,560,000 after buying an additional 44,275 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Axcelis Technologies by 1.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company’s stock valued at $3,912,000 after buying an additional 836 shares during the last quarter. Institutional investors and hedge funds own 89.98% of the company’s stock.

Wall Street Analysts Forecast Growth

ACLS has been the topic of a number of research analyst reports. Weiss Ratings cut shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, May 12th. Zacks Research raised shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Finally, B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 target price on the stock in a report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $116.25.

About Axcelis Technologies

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.